Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 10;18(12):6310.
doi: 10.3390/ijerph18126310.

Diagnostic Accuracy of a New Antigen Test for SARS-CoV-2 Detection

Affiliations

Diagnostic Accuracy of a New Antigen Test for SARS-CoV-2 Detection

Marina Di Domenico et al. Int J Environ Res Public Health. .

Abstract

Background and aims: Quick and reliable diagnostic tools play an important role in controlling the spread of the SARS-Cov-2 pandemic. The aim of this study was to evaluate the diagnostic accuracy of a new cyto-salivary antigen test aimed at detecting the presence of antigens for SARS-CoV-2, as compared by the gold standard RT-PCR and a lateral flow test.

Methods: A total of 433 healthy volunteers were enrolled in the study and the sensitivity and specificity of the new cyto-salivary antigen test were calculated, as compared to the RT-PCR nasopharyngeal swab and to the lateral flow test.

Results: A total of 433 samples were collected and tested at the Mediterranean Fair in Palermo from February 2021 until April 2021. The new cyto-salivary antigen had a sensitivity of 100% and a specificity of 94.2%. The sensitivity and the specificity of the lateral flow test were 55% and 100%, respectively.

Conclusions: The new cyto-salivary antigen test detected more positive cases than the RT-PCR in a sample of asymptomatic subjects, demonstrating to be a promising tool for a more sensitive diagnosis of COVID-19. Further studies are warranted to better characterize its diagnostic accuracy.

Keywords: ELISA; RT-PCR; SARS-CoV-2; cyto-salivary test; lateral flow test; respiratory disease COVID-19.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Venn plots show the overlapping of positive cases of the three tests performed (cyto-salivary, lateral flow and RT-PCR), n = number of positive cases.

References

    1. Centers-for-Disease-Control-and-Prevention Human Coronavirus Types. [(accessed on 23 April 2021)];2020 Available online: https://www.cdc.gov/coronavirus/types.html.
    1. Van der Hoek L. Human coronaviruses: What do they cause? Antivir. Ther. 2007;12:651–658. - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Wu J., Liang J., Zhou H., Peng F., Wang B., Jiang W., Jia B., Luo T. Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection. J. Infect. 2020;81:e102–e103. doi: 10.1016/j.jinf.2020.04.027. - DOI - PMC - PubMed
    1. Cevik M., Kuppalli K., Kindrachuk J., Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:m3862. doi: 10.1136/bmj.m3862. - DOI - PubMed